RYOIX - Rydex Biotechnology Inv

Nasdaq - Nasdaq Delayed price. Currency in USD
90.07
-0.07 (-0.08%)
At close: 8:00PM EST
Stock chart is not supported by your current browser
Previous close90.14
YTD return29.73%
Expense ratio (net)1.37%
CategoryHealth
Morningstar rating★★★☆☆
Morningstar risk ratingHigh
Last cap gain0.00
Net assets322.4M
Beta (3y)1.37
Yield0.00%
Holdings turnover207.00%
Last dividend0.00
Inception date1 Apr 1998
Average for categoryN/A
  • We're sorry we weren't able to find anything about this topic.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes